@article{Avenoso_D-2022_58075,
title = {SARS-CoV-2 infection in aplastic anaemia},
author = {Avenoso, D. and Marsh, J. and Potter, V. and Pagliuca, A. and Slade, S. and Dignan, F. and Tholouli, E. and Mittal, S. and Davis, B. and Tauro, S. and Kesse-Adu, R. and Griffin, M. and Payne, E. and Gandhi, S. and Kulasekararaj, A.},
month = {feb},
year = {2022},
abstract = {Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARSCoV- 2), was declared a pandemic by the World Health Organization in March 2020. Compared to patients with non-hematologic cancers, patients affected by hematologic disorders have increased mortality and more prolonged viral RNA persistence.Since the early phase of the pandemic, several groups have described thrombocytopenia or secondary hemophagocytic lymphohistiocytosis in patients infected by SARS-CoV-2, problems likely due to a cytokine storm and the potential cytotoxicity of the virus.},
pages = {541-543},
volume = {107},
issue = {2},
journal = {Haematologica},
publisher = {Ferrata Storti Foundation},
url = {https://doi.org/10.3324/haematol.2021.279928},
}
